Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Starpharma Releases Positive DEP® Cabazitaxel Phase 2 Interim Results in Prostate Cancer
Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing […]
Orexo Provides Information About its New Proprietary Drug Delivery Platform - AmorphOXTM
Orexo AB (publ.),(STO:ORX) (OTCQX:ORXOY) today provides information about its new proprietary drug delivery platform, amorphOXTM, a […]
Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors
Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising […]
Novartis Launches Virtual Innovation Hub to Accelerate Digital Health Solutions in Sub-Saharan Africa
Novartis has announced the launch of its new innovation hub, Novartis Biome sub-Saharan Africa (SSA), […]
Female-Owned Biotech Startup Tiamat Sciences Raises $3 Million to Manufacture Plant-Based Biomolecules
Biotechnology startup Tiamat Sciences today announced its $3 million seed financing round led by Silicon Valley venture […]
More Cancer Patients in Africa to Benefit from Advanced Radiation Therapy with Elekta Unity MR-Linac
Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less […]
More People With Diabetes Set to Benefit From Blood Sugar Monitors as NHS Roll-Out Succeeds
Half of NHS Type 1 diabetes patients in England are now benefiting from the use […]
Equality Health Appoints Garrett E. Black as Chief Operating Officer
Equality Health, a leading provider of value-based physician networks uniquely equipped to address the needs of diverse […]
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing
GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and […]
Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round
Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more